New Study uses a CRISPR-based screening approach to identify a new therapeutic target for acute myeloid leukemia. #UpennCAMB, ShiLab, PennCDB, BergerLab, PennCancer, PennEpiInst.

Previous Next
Close
Test Caption
Test Description goes like this